Evidence-Based Management of Diverticular Disease: What's New and What's Missing?

Dis Colon Rectum. 2020 Jun;63(6):715-717. doi: 10.1097/DCR.0000000000001678.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Clinical Decision-Making / methods
  • Colorectal Surgery / organization & administration
  • Constriction, Pathologic / epidemiology
  • Constriction, Pathologic / etiology
  • Diverticular Diseases / classification
  • Diverticular Diseases / complications
  • Diverticular Diseases / epidemiology
  • Diverticular Diseases / therapy*
  • Elective Surgical Procedures / methods
  • Evidence-Based Practice / standards
  • Fistula / epidemiology
  • Fistula / etiology
  • Gastrointestinal Diseases / pathology*
  • Humans
  • Mesalamine / therapeutic use
  • Meta-Analysis as Topic
  • Practice Guidelines as Topic / standards*
  • Probiotics / therapeutic use
  • Quality of Life
  • Randomized Controlled Trials as Topic
  • Rifaximin / therapeutic use
  • Societies, Scientific / organization & administration
  • United States / epidemiology

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Mesalamine
  • Rifaximin